Literature DB >> 9362466

Determination of the migratory capacity of embryonic cortical cells lacking the transcription factor Pax-6.

D Carić1, D Gooday, R E Hill, S K McConnell, D J Price.   

Abstract

The cerebral cortex forms by the orderly migration and subsequent differentiation of neuronal precursors generated in the proliferative ventricular zone. We studied the role of the transcription factor Pax-6, which is expressed in the ventricular zone, in cortical development. Embryos homozygous for a mutation of Pax-6 (Small eye; Sey) had abnormalities suggesting defective migration of late-born cortical precursors. When late-born Sey/Sey precursors were transplanted into wild-type embryonic rat cortex, they showed similar integrative, migrational and differentiative abilities to those of transplanted wild-type mouse precursors. These results suggest that postmitotic cortical cells do not need Pax-6 to acquire the capacity to migrate and differentiate, but that Pax-6 generates a cortical environment that permits later-born precursors to express their full developmental potential.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362466     DOI: 10.1242/dev.124.24.5087

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  34 in total

Review 1.  Neuronal migration disorders in humans and in mouse models--an overview.

Authors:  A J Copp; B N Harding
Journal:  Epilepsy Res       Date:  1999-09       Impact factor: 3.045

2.  Defect of tyrosine hydroxylase-immunoreactive neurons in the brains of mice lacking the transcription factor Pax6.

Authors:  T Vitalis; O Cases; D Engelkamp; C Verney; D J Price
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

3.  Crystal structure of the human Pax6 paired domain-DNA complex reveals specific roles for the linker region and carboxy-terminal subdomain in DNA binding.

Authors:  H E Xu; M A Rould; W Xu; J A Epstein; R L Maas; C O Pabo
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

4.  Sequential phases of cortical specification involve Neurogenin-dependent and -independent pathways.

Authors:  Carol Schuurmans; Olivier Armant; Marta Nieto; Jan M Stenman; Olivier Britz; Natalia Klenin; Craig Brown; Lisa-Marie Langevin; Julie Seibt; Hua Tang; James M Cunningham; Richard Dyck; Christopher Walsh; Kenny Campbell; Franck Polleux; François Guillemot
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

5.  A binding site for homeodomain and Pax proteins is necessary for L1 cell adhesion molecule gene expression by Pax-6 and bone morphogenetic proteins.

Authors:  R Meech; P Kallunki; G M Edelman; F S Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Cell migration in Drosophila optic lobe neurons is controlled by eyeless/Pax6.

Authors:  Javier Morante; Ted Erclik; Claude Desplan
Journal:  Development       Date:  2011-01-05       Impact factor: 6.868

7.  Selective requirement of Pax6, but not Emx2, in the specification and development of several nuclei of the amygdaloid complex.

Authors:  Shubha Tole; Ryan Remedios; Bhaskar Saha; Anastassia Stoykova
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

8.  Emx1-lineage progenitors differentially contribute to neural diversity in the striatum and amygdala.

Authors:  Laura A Cocas; Goichi Miyoshi; Rosalind S E Carney; Vitor H Sousa; Tsutomu Hirata; Kevin R Jones; Gord Fishell; Molly M Huntsman; Joshua G Corbin
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

9.  The Tlx gene regulates the timing of neurogenesis in the cortex.

Authors:  Kristine Roy; Kathleen Kuznicki; Qiang Wu; Zhuoxin Sun; Dagmar Bock; Gunther Schutz; Nancy Vranich; A Paula Monaghan
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

10.  Novel lines of Pax6-/- embryonic stem cells exhibit reduced neurogenic capacity without loss of viability.

Authors:  Jane C Quinn; Michael Molinek; Tomasz J Nowakowski; John O Mason; David J Price
Journal:  BMC Neurosci       Date:  2010-02-24       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.